The Trump administration canceled a $1.2 million National Institutes of Health (NIH) grant to the University of Alabama at Birmingham (UAB) last week.
According to the U.S. Department of Health and Human Services (HHS), the canceled UAB grant and others are listed online in accordance with the Trump memo "Radical Transparency About Wasteful Spending."
The grant-funded study is titled "Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups with Rheumatic Diseases." HHS canceled the grant on April 1 with $500,190.27 of the $1,261,705 total funding left unspent.
According to a description of the study, the "study aims to test whether a novel intervention using first-person narratives (i.e., "storytelling") recounting personal experiences with the COVID-19 vaccination as well as patient navigation to provide logistics support for and reinforce safety and effectiveness of COVID-19 vaccination will result in an increase in vaccination uptake among Black and Latinx adults with (autoimmune rheumatic diseases)."
"This proposal will harness community-engaged methods to develop and test the effectiveness of a multi-modal intervention that combines "storytelling" videos and patient navigation to increase uptake of recommended COVID-19 vaccination among Black and Latinx (autoimmune rheumatic diseases) patients in two distinct US geographic regions," the study description said.
The project leader of the study was Dr. Maria Danila, a professor of medicine at UAB, according to NIH.
Other grants to UAB canceled by the Trump administration and HHS Secretary Robert F. Kennedy, Jr. in recent weeks can be found here.
HHS Grants Terminated4 by Caleb Taylor on Scribd
To connect with the author of this story or to comment, email [email protected].
Don't miss out! Subscribe to our newsletter and get our top stories every weekday morning.
